Table 1.
The baseline characteristics of the groups and laboratory findings for both groups at 6 month follow-up
| Group 1a (n = 68) | Group 2b (n = 32) | Control group (n = 50) | p value | |
|---|---|---|---|---|
| Age (years), mean ± SD | 38.18 ± 10.38 | 43.56 ± 10.9 | 39.76 ± 12.47 | 0.08 |
| Sex (M), n (%) | 35 (51.5) | 14 (43.8) | 27 (54) | 0.65 |
| BMI (kg/m2), mean ± SD | 25.42 ± 3.09 | 25.17 ± 1.81 | 25.31 ± 2.78 | 0.66 |
| HT, n (%) | 34 (50) | 19 (59.4) | 25 (50) | 0.51 |
| Smoking, n (%) | 18 (26.5) | 12 (37.5) | 19 (38) | 0.002 |
| HL n (%) | 19 (27.9) | 8 (25) | 11 (22) | 0.63 |
| Glu, mg/dl, median (IQR) | 97 (87.2-101.7) | 91 (88-102.2) | 94 (88.7-100.5) | 0.89 |
| Cre, mg/dl, mean ± SD | 0.8 ± 0.19 | 0.9 ± 0.15 | 0.91 ± 0.11 | 0.67 |
| WBC (10 9/l), median (IQR) | 9.2 (6.8–13) | 8.7 (7–11.8) | 7 (5.8–8) | <0.001 |
| Hb (g/dl), median (IQR) | 12.9 (12.1–13.5) | 12.5 (11.9–13.5) | 12.9 (12.1–13.5) | 0.65 |
| PC (10 9/l), mean ± SD | 273.5 ± 47.1 | 319.6 ± 43.4 | 306.1 ± 47.9 | <0.001 |
BMI body mass index, HT hypertension, HL hyperlipidemia, Glu glucose, Cre creatinine, WBC white blood cell count, Hb haemoglobin, PC platelet count
aPatients with residual venous thrombosis
bPatients with complete resolution of thrombus